Richard A. Barasch - 24 Jul 2025 Form 4 Insider Report for Oncology Institute, Inc. (TOI)

Reporting relationship: Director
Issuer ticker: TOI
Reported as of: 24 Jul 2025
Net transaction value: $0
SEC form: 4
Accepted by SEC: 28 Jul 2025, 21:08:48 UTC
Prior SEC filing: 20 Jun 2025
Next SEC filing: 14 Aug 2025
Source filing: View source filing
Reporting owner signature: /s/ Mark Hueppelsheuser, Attorney in fact for Richard Barasch

Key filing fact

Richard A. Barasch filed Form 4 for Oncology Institute, Inc. (TOI) on 28 Jul 2025.

Key facts

This page summarizes Richard A. Barasch's Form 4 filing for Oncology Institute, Inc. (TOI).
1 reported transaction and 0 derivative rows are listed below.
Accepted by SEC: 28 Jul 2025, 21:08.

Change

Previous filing in this sequence was filed on 20 Jun 2025.
Current net transaction value: $0.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reporting Owners (1)

CIK 0001076341 Primary reporting owner

BARASCH RICHARD A

Relationship: Director
Address: C/O ONCOLOGY INSTITUTE, INC., 18000 STUDEBAKER RD. SUITE 800, CERRITOS
Signature: /s/ Mark Hueppelsheuser, Attorney in fact for Richard Barasch
Signature date: 28 Jul 2025

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

TOI transaction

Common Stock

Other

Transaction value: $0
Shares: -287,756
Change %: -9.8%
Price: $0.000000
Shares after: 2,635,881
Date: 24 Jul 2025
Ownership: By LLC
Footnotes: F1, F2

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 2 footnotes

Footnote F1

RAB Ventures (DFP) LLC ("RAB Ventures") distributed 287,756 shares to one of its members, Boro Partners Fund 1 ("Boro") in accordance with Boro's beneficial interest in RAB Ventures. The reporting person is a 10% beneficial owner of Boro, but disclaims investment control over Boro. The reporting person disclaims beneficial ownership of these securities except to the extent of the reporting person's pecuniary interest therein.

Footnote F2

The distributed shares were owned by RAB Ventures, an entity controlled by the reporting person.